Clinton Proposes New Law on Patient Privacy

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 6 No 9
Volume 6
Issue 9

WASHINGTON-The Clinton Administration soon will propose a federal law aimed at protecting the privacy of medical records. The law would allow disclosure of medical records only for reasons of health care. For example, if an employer gained access to an employee’s records during the claims process, the company would not be allowed to use the information in any way that would affect the employee’s job, such as in considering promotions or assignments.

WASHINGTON—The Clinton Administration soon will propose a federal law aimed at protecting the privacy of medical records. The law would allow disclosure of medical records only for reasons of health care. For example, if an employer gained access to an employee’s records during the claims process, the company would not be allowed to use the information in any way that would affect the employee’s job, such as in considering promotions or assignments.

The proposed legislation would allow patients to receive copies of their medical records, give them the chance to correct mistakes in the records, and allow them to see who has been requesting their records.

Further, the law would hold insurers to the same disclosure standards as doctors and hospitals. Finally, anyone who disclosed medical records improperly or who used subterfuge to obtain the records would be subject to criminal penalties.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Patients treated with nivolumab in the phase 3 CheckMate 577 trial were less likely to experience progression-related treatment discontinuation vs placebo.
2 experts in this video
2 experts in this video
Considering which non–muscle-invasive bladder cancer cases may be cured by surgery alone may help mitigate overtreatment in this patient group.
Event-free survival benefit was observed among BCG-naïve patients with carcinoma in situ undergoing treatment with sasanlimab plus BCG.
Related Content